The EC1 study v1
Research type
Research Study
Full title
The role of the endocannabinoid system and cannabis use in the expression of psychosis
IRAS ID
322894
Contact name
Diego Quattrone
Contact email
Sponsor organisation
South London and Maudsley NHS Foundation Trust
Clinicaltrials.gov Identifier
NA, NA
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
As England might legalise cannabis for recreational use, we need to know how it can lead to psychosis. Psychosis is a mental health condition where people often lose touch with reality for given periods of time. Cannabis-users are at a higher risk of becoming psychotic and more violent than others.
This study explores why cannabis use can result in aggressive and violent psychiatric patients. The findings could help us to better understand how cannabis affects mental health and to better help prevent psychosis, making wards (and society) safer. Also, the findings may help us understand why some people's mental health is more at risk from cannabis' effects and not others.
REC name
South West - Frenchay Research Ethics Committee
REC reference
24/SW/0151
Date of REC Opinion
3 Feb 2025
REC opinion
Further Information Favourable Opinion